Longeveron announced the election of three new directors to serve on the Longeveron Board of Directors. Wa’el Hashad, Khoso Baluch, and Jeffrey Pfeffer were elected at the Company’s Annual Meeting of Stockholders, held Friday June 9, 2023, and will serve until the 2026 Annual Meeting of Stockholders, or until their successors are duly elected. Concurrent with the election of the new Directors, the terms of Donald Soffer, Erin Borger, and Todd Girolamo to serve as directors expired. Wa’el Hashad has served as CEO of Longeveron since February, 2023. Khoso Baluch has served as an independent director of Poxel S.A., a French publicly traded biotech company, chairs its compensation committee and as of March 2023 became Chairman. Jeffrey Pfeffer is the Thomas D. Dee II Professor of Organizational Behavior at the Graduate School of Business, Stanford University, where he has taught since 1979.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on LGVN:
- Longeveron Welcomes Three New Prominent Board Members
- Longeveron Inc. Provides Corporate Update and Reports First Quarter 2023 Financial Results
- LGVN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Longeveron Announces New Long-Term Survival Data from ELPIS I Trial of Lomecel-B™ for Hypoplastic Left Heart Syndrome
- Longeveron to Announce First Quarter 2023 Financial Results on May 12, 2023